Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Synthetic Biologics Inc closes public offering of common stock


Tuesday, 17 Dec 2013 12:38pm EST 

Synthetic Biologics Inc:Says the closing of a previously announced underwritten public offering of 13,225,000 shares of its common stock, including the fully exercised over-allotment option by the underwriters covering 1,725,000 shares, offered at a price to the public of US$1.00 per share.Says the gross proceeds to the company were US$13,225,000, before deducting underwriting discounts, commissions and other offering expenses payable by the company.Says Aegis Capital Corp. acted as sole book-running manager of the offering. 

Company Quote

1.52
-0.05 -3.18%
24 Jul 2014